1. Arends JW, Verstynen C, Bossmann FT, Hilgers J, Steplewski Z (1983) Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues ? an immunperoxidase study. Hybridoma 2:219
2. Akinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H (1982) Gastrointestinal cancer-associated antigen in immunperoxidase assay. Cancer Res 42:4280
3. Bätge B, Bosslet K, Sedlacek HH, Kern MF, Göppel G (1986) Monoclonal antibodies against CEA-related components discriminate between pankreatic duct type carcinomas and non-neoplasiac duct lesions as well as nonduct-type neoplasias. Virchows Arch (Pathol Anat) 408:361
4. Beger HG, Büchler M, Kübel R (1986) Preliminary results of monoclonal antibody treatment in patients with unresectable pancreatic cancer. Int J Pancreatol (im Druck)
5. Borowitz MJ, Tuck FL, Sindelar WF, Fernsten PhD, Metzger RS (1984) Monoclonal antibodies against human pancreatic adenocarcinoma. Distribution of DU-PAN-2 antigen on glandular epithelia and andenocarcinomas. JNCI 72:999